EconPapers    
Economics at your fingertips  
 

Can we Reduce the Cost of Treatment of Acute Pneumonia?

Igor Klepikov
Additional contact information
Igor Klepikov: Dana Children’s Hospital, Russia

Modern Applications of Bioequivalence & Bioavailability, 2017, vol. 1, issue 1, 1-2

Abstract: If you have serious medical problems, threatening the patient’s life, the costs of treatment are retreating to the sidelines. In these moments all thoughts and aspirations aim to eliminate the problem. Psychological shock of patients with complicated forms of acute pneumonia (AP) can hardly be accurately evaluated and compensated by a monetary amount. Psychological and moral experiences of relatives of the patient and the attending medical staff also cannot be represented in the form of financial calculations. All these factors can only serve as an additional incentive for finding a solution of the problem. However, material support of the treatment process can be counted, from the economic point of view, sufficiently detailed and precise.

Keywords: bioavailability and bioequivalence; bioavailability and bioequivalence pdf; bioavailability formula; open access; open access journals; juniper publishers review; high impact journals; peer reviewed journals; online journals publishers (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/mabb/pdf/MABB.MS.ID.555551.pdf (application/pdf)
https://juniperpublishers.com/mabb/MABB.MS.ID.555551.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:oamabb:v:1:y:2017:i:1:p:1-2

DOI: 10.19080/MABB.2017.01.555551

Access Statistics for this article

Modern Applications of Bioequivalence & Bioavailability is currently edited by Sophia Mathis

More articles in Modern Applications of Bioequivalence & Bioavailability from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().

 
Page updated 2025-03-19
Handle: RePEc:adp:oamabb:v:1:y:2017:i:1:p:1-2